SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-154514
Filing Date
2018-05-07
Accepted
2018-05-07 16:30:56
Documents
5
Period of Report
2018-05-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d563895d8k.htm 8-K 23736
2 EXHIBIT 3.1 d563895dex31.htm EX-3.1 24959
3 EXHIBIT 3.2 d563895dex32.htm EX-3.2 169372
4 EXHIBIT 99.1 d563895dex991.htm EX-99.1 6009
5 GRAPHIC g563895aaa.jpg GRAPHIC 13647
  Complete submission text file 0001193125-18-154514.txt   244349
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 18811648
SIC: 2834 Pharmaceutical Preparations